102 related articles for article (PubMed ID: 17470194)
1. Is the concept of 'cardiometabolic risk' more useful than 'metabolic syndrome'?
Koshiyama H; Taniguchi A; Inagaki N; Seino Y
Diabet Med; 2007 May; 24(5):571. PubMed ID: 17470194
[No Abstract] [Full Text] [Related]
2. New insights into understanding cardiometabolic risk. Introduction.
Fonarow GC; Watson KE
Rev Cardiovasc Med; 2007; 8 Suppl 4():S1-2. PubMed ID: 17934389
[No Abstract] [Full Text] [Related]
3. Cardiovascular outcomes for obesity and metabolic syndrome.
Vega GL
Obes Res; 2002 Nov; 10 Suppl 1():27S-32S. PubMed ID: 12446855
[No Abstract] [Full Text] [Related]
4. Mixed dyslipidemia, metabolic syndrome, diabetes mellitus, and cardiovascular disease: clinical implications.
Cannon CP
Am J Cardiol; 2008 Dec; 102(12A):5L-9L. PubMed ID: 19084083
[TBL] [Abstract][Full Text] [Related]
5. The concept of cardiometabolic risk: Bridging the fields of diabetology and cardiology.
Després JP; Cartier A; Côté M; Arsenault BJ
Ann Med; 2008; 40(7):514-23. PubMed ID: 18608131
[TBL] [Abstract][Full Text] [Related]
6. I read that nearly a quarter of adult Americans have "metabolic syndrome". What is this malady, and how can I prevent it?
Blackburn GL
Health News; 2002 Nov; 8(11):12. PubMed ID: 12523258
[No Abstract] [Full Text] [Related]
7. [Metabolic syndrome as a precursor of diabetes mellitus type 2 and cardiovascular diseases].
Shestakova MV; Butrova SA; Sukhareva OIu
Ter Arkh; 2007; 79(10):5-8. PubMed ID: 18154136
[No Abstract] [Full Text] [Related]
8. CVD risk assessment: do we need the metabolic syndrome or better global cardiometabolic risk calculators?
Després JP
Int J Obes (Lond); 2008 May; 32 Suppl 2():S1-4. PubMed ID: 18469833
[No Abstract] [Full Text] [Related]
9. Pancreatic renin-angiotensin-aldosterone system in the cardiometabolic syndrome and type 2 diabetes mellitus.
Hayden MR; Sowers JR
J Cardiometab Syndr; 2008; 3(3):129-31. PubMed ID: 18983326
[No Abstract] [Full Text] [Related]
10. The cardiometabolic syndrome in the adolescent.
Gardner M; Gardner DW; Sowers JR
Pediatr Endocrinol Rev; 2008 Aug; 5 Suppl 4():964-8. PubMed ID: 18806711
[TBL] [Abstract][Full Text] [Related]
11. Fenofibrate for cardiovascular disease prevention in metabolic syndrome and type 2 diabetes mellitus.
Steiner G
Am J Cardiol; 2008 Dec; 102(12A):28L-33L. PubMed ID: 19084087
[TBL] [Abstract][Full Text] [Related]
12. The metabolic syndrome and risk of cardiovascular disease and diabetes: experiences with the new diagnostic criteria from the International Diabetes Federation.
Saely CH; Rein P; Drexel H
Horm Metab Res; 2007 Sep; 39(9):642-50. PubMed ID: 17846971
[TBL] [Abstract][Full Text] [Related]
13. Reducing cardiovascular risk in metabolic syndrome and type 2 diabetes mellitus beyond low-density lipoprotein cholesterol lowering: a role for fenofibrate. Introduction.
Sacks FM
Am J Cardiol; 2008 Dec; 102(12A):1L-3L. PubMed ID: 19084082
[No Abstract] [Full Text] [Related]
14. [The metabolic syndrome threatens public health. Increased physical activity the best cure].
Hellénius ML; Rauramaa R
Lakartidningen; 2007 Dec; 104(51-52):3857-61. PubMed ID: 18232526
[No Abstract] [Full Text] [Related]
15. The metabolic syndrome: mechanisms, epidemiology, and clinical implications.
Postgrad Med; 2003 Dec; 114(6 Suppl Managing Metabolic):17-27. PubMed ID: 19667650
[TBL] [Abstract][Full Text] [Related]
16. Unmet needs in controlling metabolic disease.
Haffner SM
Rev Cardiovasc Med; 2007; 8 Suppl 4():S17-24. PubMed ID: 17934390
[TBL] [Abstract][Full Text] [Related]
17. Abdominal adiposity and cardiometabolic risk: do we have all the answers?
Haffner SM
Am J Med; 2007 Sep; 120(9 Suppl 1):S10-6; discussion S16-7. PubMed ID: 17720354
[TBL] [Abstract][Full Text] [Related]
18. Pathophysiology of the metabolic syndrome: implications for the cardiometabolic risks associated with type 2 diabetes.
Leroith D
Am J Med Sci; 2012 Jan; 343(1):13-6. PubMed ID: 22205060
[TBL] [Abstract][Full Text] [Related]
19. Why metabolic syndrome criteria have not made prime time: a view from the clinic.
Sattar N
Int J Obes (Lond); 2008 May; 32 Suppl 2():S30-4. PubMed ID: 18469837
[TBL] [Abstract][Full Text] [Related]
20. Effect of metabolic syndrome or type II diabetes mellitus on the occurrence of recurrent vascular events in hypertensive patients.
Vlek AL; van der Graaf Y; Spiering W; Visseren FL;
J Hum Hypertens; 2008 May; 22(5):358-65. PubMed ID: 18273039
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
